Updated Jul 16, 2026
Patience David has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $32K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TLSI | TriSalus Life Sciences, Inc. | F — Tax withholding / forfeiture | 14.7K | $4.46 | $65K |
| 2026-05-18 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 7.1K | $2.43 | $17K |
| 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 3.7K | $4.10 | $15K |
| 2025-08-14 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 200.0K | $0.00 |
Patience David is a corporate insider — currently tracked as Chief Financial Officer of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($32K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patience David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.